Alamar Biosciences, Inc.
ALMRNasdaq
$25.95
↑ +4.0%Jul 17 close · end-of-day
Price
1Y↑ +18.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
Our mission is to power precision proteomics to enable the earliest detection of disease. We are a commercial-stage proteomics company establishing a gold standard in protein detection and analysis. Our principal executive offices are located in Fremont, California.
- CEO
- Yuling Luo
- Sector
- Manufacturing
- Industry
- Measuring And Control Equipment
- Employees
- 222
- Headquarters
- California
- Website
- alamarbio.com
Management & directors
- Chen ShipingChief Operating Officer
- Luo YulingChief Executive Officer
- Mcanear Justin J.Chief Financial Officer
- White Timothy OgdenPresident
Roles derived from SEC Form 4 filings.
Earnings
ALMR Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$26.0M↑ +98.9%
Diluted EPS-$1.74↑ +155.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
No annual data.
| Line item | Q1 '25 | Q1 '26 |
|---|---|---|
| Revenue | $13.1M | $26.0M |
| Gross profit | $6.4M | $14.5M |
| Operating income | -$8.6M | -$12.3M |
| Net income | -$7.7M | -$21.3M |
| Diluted EPS | -$0.68 | -$1.74 |
| Operating cash flow | -$13.1M | -$20.3M |
| Free cash flow | -$13.6M | -$20.9M |
| Gross margin | 48.8% | 55.5% |
| Operating margin | -65.3% | -47.4% |
| Net margin | -58.5% | -81.9% |
Company news
Jul 14, 2026
Jul 13, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-20 | Naclerio Nicholas | Buy | 235,294 | $17.00 | $4.0M | filing |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | Buy | 235,294 | $17.00 | $4.0M | filing |
| 2026-04-20 | White Timothy Ogden· President | Award | 37,220 | $0.00 | $0.00 | filing |
| 2026-04-20 | Chen Shiping· Chief Operating Officer | J | 722,885 | $0.00 | $0.00 | filing |
| 2026-04-20 | McAnear Justin J.· Chief Financial Officer | Award | 37,220 | $0.00 | $0.00 | filing |
| 2026-04-20 | Chen Shiping· Chief Operating Officer | Award | 37,220 | $0.00 | $0.00 | filing |
| 2026-04-20 | Naclerio Nicholas | Award | 5,686 | $0.00 | $0.00 | filing |
| 2026-04-20 | Luo Yuling· Chief Executive Officer | Award | 76,509 | $0.00 | $0.00 | filing |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | J | 185,163 | — | — | filing |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | J | 6,881,410 | — | — | filing |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | J | 1,605,645 | — | — | filing |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | J | 1,922,329 | — | — | filing |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | C | 4,588,364 | — | — | filing |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | C | 922,152 | — | — | filing |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | J | 5,510,516 | — | — | filing |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | J | 5,510,516 | — | — | filing |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | C | 346,020 | — | — | filing |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | C | 271,782 | — | — | filing |
| 2026-04-20 | White Timothy Ogden· President | J | 454,583 | — | — | filing |
| 2026-04-20 | White Timothy Ogden· President | J | 454,583 | — | — | filing |
| 2026-04-20 | Chen Shiping· Chief Operating Officer | C | 320,511 | — | — | filing |
| 2026-04-20 | Chen Shiping· Chief Operating Officer | C | 72,853 | — | — | filing |
| 2026-04-20 | Chen Shiping· Chief Operating Officer | J | 722,885 | — | — | filing |
| 2026-04-20 | Luo Yuling· Chief Executive Officer | C | 1,386,746 | — | — | filing |
| 2026-04-20 | Luo Yuling· Chief Executive Officer | C | 364,268 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.